Baidu
map

机器人微创手术模拟培训项目启动

2016-03-21 时文 科学网

由吴阶平医学基金会和全球医生组织联合共建的“国际规范化微创手术机器人3D模拟培训项目”签字仪式3月18日在北京举行,该项目将填补我国在微创手术机器人模拟培训这一领域的空白。 外科手术经历了上百年的发展历程,已经从开放式、微创式、已进入21世纪的智能机器人时代。在过去十年里,以达芬奇机器人为代表的微创外科机器人技术已经进入了成熟发展期,在临床上,机器人手术系统已经被广泛应用于泌尿外科、妇外科、普外

由吴阶平医学基金会和全球医生组织联合共建的“国际规范化微创手术机器人3D模拟培训项目”签字仪式3月18日在北京举行,该项目将填补我国在微创手术机器人模拟培训这一领域的空白。

外科手术经历了上百年的发展历程,已经从开放式、微创式、已进入21世纪的智能机器人时代。在过去十年里,以达芬奇机器人为代表的微创外科机器人技术已经进入了成熟发展期,在临床上,机器人手术系统已经被广泛应用于泌尿外科、妇外科、普外科、心胸外科等领域。全球每年的手术量突破百万例。

与传统的开放式手术和腔镜微创手术不同,机器人辅助微创手术需要严格的专业技能模拟培训。类似培训专业飞行员一样,需要在飞行模拟器经过模拟飞行训练和考核。在欧美医疗机构中,外科医生,特别是青年医生,接受机器人手术模拟培训已成为标准化外科手术技能的培养。但目前我国在微创手术机器人技能培训方面的状况是,还没有规范化、国际标准机器人手术模拟培训中心或设施。没有机器人手术模拟培训教程和手术观摩课件,没有经过严格培训的师资等。据不完全统计,我国目前大型三甲医院已装备了近50台达芬奇机器人系统。预期2018年底,累计装机量将突破100台。但随着智能机器人手术的普及应用,外科医生急需建立机器人手术专业规范和标准,特别是机器人专项技能的专业培训。

机器人微创手术模拟培训项目将以现有达芬奇机器人系统的医院为核心,逐步拓展到所有外科临床住院医师;模拟培训课程的设计规划,完全是按照国际同行的最高标准和科学设计理念。合作双方将发挥双方各自优势,整合国内外专家和研究型医院协作资源,在培训教程成熟后,上报给政府监管和医疗技术考评机构并建立中国的机器人微创手术技术资质考评体系。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1309471, encodeId=8c8513094e120, content=<a href='/topic/show?id=64ee5052ea7' target=_blank style='color:#2F92EE;'>#微创手术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50527, encryptionId=64ee5052ea7, topicName=微创手术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2b9b368, createdName=qingrejiedu, createdTime=Wed Mar 23 00:02:00 CST 2016, time=2016-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1316966, encodeId=b8b11316966e5, content=<a href='/topic/show?id=df8950505a2' target=_blank style='color:#2F92EE;'>#微创#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50505, encryptionId=df8950505a2, topicName=微创)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=644e456, createdName=vera_1203, createdTime=Wed Mar 23 00:02:00 CST 2016, time=2016-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1321877, encodeId=9d5713218e7e1, content=<a href='/topic/show?id=890c611854e' target=_blank style='color:#2F92EE;'>#机器人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61185, encryptionId=890c611854e, topicName=机器人)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d139492, createdName=xue8602, createdTime=Wed Mar 23 00:02:00 CST 2016, time=2016-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1582939, encodeId=2cc51582939f5, content=<a href='/topic/show?id=f6e1611840d' target=_blank style='color:#2F92EE;'>#机器#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61184, encryptionId=f6e1611840d, topicName=机器)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13dc16973127, createdName=ms6279672939590805, createdTime=Wed Mar 23 00:02:00 CST 2016, time=2016-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=72585, encodeId=24e3e258580, content=没有这个条件阿, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a6a1604604, createdName=Gsurgeon, createdTime=Tue Mar 22 11:47:00 CST 2016, time=2016-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=72563, encodeId=4197e256309, content=想参加, beContent=null, objectType=article, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=115b1703046, createdName=1de8665bm23(暂无匿称), createdTime=Tue Mar 22 09:08:00 CST 2016, time=2016-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=72437, encodeId=1214e243721, content=厉害厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Mon Mar 21 21:50:00 CST 2016, time=2016-03-21, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1309471, encodeId=8c8513094e120, content=<a href='/topic/show?id=64ee5052ea7' target=_blank style='color:#2F92EE;'>#微创手术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50527, encryptionId=64ee5052ea7, topicName=微创手术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2b9b368, createdName=qingrejiedu, createdTime=Wed Mar 23 00:02:00 CST 2016, time=2016-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1316966, encodeId=b8b11316966e5, content=<a href='/topic/show?id=df8950505a2' target=_blank style='color:#2F92EE;'>#微创#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50505, encryptionId=df8950505a2, topicName=微创)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=644e456, createdName=vera_1203, createdTime=Wed Mar 23 00:02:00 CST 2016, time=2016-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1321877, encodeId=9d5713218e7e1, content=<a href='/topic/show?id=890c611854e' target=_blank style='color:#2F92EE;'>#机器人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61185, encryptionId=890c611854e, topicName=机器人)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d139492, createdName=xue8602, createdTime=Wed Mar 23 00:02:00 CST 2016, time=2016-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1582939, encodeId=2cc51582939f5, content=<a href='/topic/show?id=f6e1611840d' target=_blank style='color:#2F92EE;'>#机器#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61184, encryptionId=f6e1611840d, topicName=机器)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13dc16973127, createdName=ms6279672939590805, createdTime=Wed Mar 23 00:02:00 CST 2016, time=2016-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=72585, encodeId=24e3e258580, content=没有这个条件阿, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a6a1604604, createdName=Gsurgeon, createdTime=Tue Mar 22 11:47:00 CST 2016, time=2016-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=72563, encodeId=4197e256309, content=想参加, beContent=null, objectType=article, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=115b1703046, createdName=1de8665bm23(暂无匿称), createdTime=Tue Mar 22 09:08:00 CST 2016, time=2016-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=72437, encodeId=1214e243721, content=厉害厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Mon Mar 21 21:50:00 CST 2016, time=2016-03-21, status=1, ipAttribution=)]
    2016-03-23 vera_1203
  3. [GetPortalCommentsPageByObjectIdResponse(id=1309471, encodeId=8c8513094e120, content=<a href='/topic/show?id=64ee5052ea7' target=_blank style='color:#2F92EE;'>#微创手术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50527, encryptionId=64ee5052ea7, topicName=微创手术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2b9b368, createdName=qingrejiedu, createdTime=Wed Mar 23 00:02:00 CST 2016, time=2016-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1316966, encodeId=b8b11316966e5, content=<a href='/topic/show?id=df8950505a2' target=_blank style='color:#2F92EE;'>#微创#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50505, encryptionId=df8950505a2, topicName=微创)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=644e456, createdName=vera_1203, createdTime=Wed Mar 23 00:02:00 CST 2016, time=2016-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1321877, encodeId=9d5713218e7e1, content=<a href='/topic/show?id=890c611854e' target=_blank style='color:#2F92EE;'>#机器人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61185, encryptionId=890c611854e, topicName=机器人)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d139492, createdName=xue8602, createdTime=Wed Mar 23 00:02:00 CST 2016, time=2016-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1582939, encodeId=2cc51582939f5, content=<a href='/topic/show?id=f6e1611840d' target=_blank style='color:#2F92EE;'>#机器#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61184, encryptionId=f6e1611840d, topicName=机器)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13dc16973127, createdName=ms6279672939590805, createdTime=Wed Mar 23 00:02:00 CST 2016, time=2016-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=72585, encodeId=24e3e258580, content=没有这个条件阿, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a6a1604604, createdName=Gsurgeon, createdTime=Tue Mar 22 11:47:00 CST 2016, time=2016-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=72563, encodeId=4197e256309, content=想参加, beContent=null, objectType=article, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=115b1703046, createdName=1de8665bm23(暂无匿称), createdTime=Tue Mar 22 09:08:00 CST 2016, time=2016-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=72437, encodeId=1214e243721, content=厉害厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Mon Mar 21 21:50:00 CST 2016, time=2016-03-21, status=1, ipAttribution=)]
    2016-03-23 xue8602
  4. [GetPortalCommentsPageByObjectIdResponse(id=1309471, encodeId=8c8513094e120, content=<a href='/topic/show?id=64ee5052ea7' target=_blank style='color:#2F92EE;'>#微创手术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50527, encryptionId=64ee5052ea7, topicName=微创手术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2b9b368, createdName=qingrejiedu, createdTime=Wed Mar 23 00:02:00 CST 2016, time=2016-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1316966, encodeId=b8b11316966e5, content=<a href='/topic/show?id=df8950505a2' target=_blank style='color:#2F92EE;'>#微创#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50505, encryptionId=df8950505a2, topicName=微创)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=644e456, createdName=vera_1203, createdTime=Wed Mar 23 00:02:00 CST 2016, time=2016-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1321877, encodeId=9d5713218e7e1, content=<a href='/topic/show?id=890c611854e' target=_blank style='color:#2F92EE;'>#机器人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61185, encryptionId=890c611854e, topicName=机器人)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d139492, createdName=xue8602, createdTime=Wed Mar 23 00:02:00 CST 2016, time=2016-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1582939, encodeId=2cc51582939f5, content=<a href='/topic/show?id=f6e1611840d' target=_blank style='color:#2F92EE;'>#机器#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61184, encryptionId=f6e1611840d, topicName=机器)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13dc16973127, createdName=ms6279672939590805, createdTime=Wed Mar 23 00:02:00 CST 2016, time=2016-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=72585, encodeId=24e3e258580, content=没有这个条件阿, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a6a1604604, createdName=Gsurgeon, createdTime=Tue Mar 22 11:47:00 CST 2016, time=2016-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=72563, encodeId=4197e256309, content=想参加, beContent=null, objectType=article, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=115b1703046, createdName=1de8665bm23(暂无匿称), createdTime=Tue Mar 22 09:08:00 CST 2016, time=2016-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=72437, encodeId=1214e243721, content=厉害厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Mon Mar 21 21:50:00 CST 2016, time=2016-03-21, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1309471, encodeId=8c8513094e120, content=<a href='/topic/show?id=64ee5052ea7' target=_blank style='color:#2F92EE;'>#微创手术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50527, encryptionId=64ee5052ea7, topicName=微创手术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2b9b368, createdName=qingrejiedu, createdTime=Wed Mar 23 00:02:00 CST 2016, time=2016-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1316966, encodeId=b8b11316966e5, content=<a href='/topic/show?id=df8950505a2' target=_blank style='color:#2F92EE;'>#微创#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50505, encryptionId=df8950505a2, topicName=微创)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=644e456, createdName=vera_1203, createdTime=Wed Mar 23 00:02:00 CST 2016, time=2016-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1321877, encodeId=9d5713218e7e1, content=<a href='/topic/show?id=890c611854e' target=_blank style='color:#2F92EE;'>#机器人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61185, encryptionId=890c611854e, topicName=机器人)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d139492, createdName=xue8602, createdTime=Wed Mar 23 00:02:00 CST 2016, time=2016-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1582939, encodeId=2cc51582939f5, content=<a href='/topic/show?id=f6e1611840d' target=_blank style='color:#2F92EE;'>#机器#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61184, encryptionId=f6e1611840d, topicName=机器)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13dc16973127, createdName=ms6279672939590805, createdTime=Wed Mar 23 00:02:00 CST 2016, time=2016-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=72585, encodeId=24e3e258580, content=没有这个条件阿, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a6a1604604, createdName=Gsurgeon, createdTime=Tue Mar 22 11:47:00 CST 2016, time=2016-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=72563, encodeId=4197e256309, content=想参加, beContent=null, objectType=article, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=115b1703046, createdName=1de8665bm23(暂无匿称), createdTime=Tue Mar 22 09:08:00 CST 2016, time=2016-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=72437, encodeId=1214e243721, content=厉害厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Mon Mar 21 21:50:00 CST 2016, time=2016-03-21, status=1, ipAttribution=)]
    2016-03-22 Gsurgeon

    没有这个条件阿

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1309471, encodeId=8c8513094e120, content=<a href='/topic/show?id=64ee5052ea7' target=_blank style='color:#2F92EE;'>#微创手术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50527, encryptionId=64ee5052ea7, topicName=微创手术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2b9b368, createdName=qingrejiedu, createdTime=Wed Mar 23 00:02:00 CST 2016, time=2016-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1316966, encodeId=b8b11316966e5, content=<a href='/topic/show?id=df8950505a2' target=_blank style='color:#2F92EE;'>#微创#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50505, encryptionId=df8950505a2, topicName=微创)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=644e456, createdName=vera_1203, createdTime=Wed Mar 23 00:02:00 CST 2016, time=2016-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1321877, encodeId=9d5713218e7e1, content=<a href='/topic/show?id=890c611854e' target=_blank style='color:#2F92EE;'>#机器人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61185, encryptionId=890c611854e, topicName=机器人)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d139492, createdName=xue8602, createdTime=Wed Mar 23 00:02:00 CST 2016, time=2016-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1582939, encodeId=2cc51582939f5, content=<a href='/topic/show?id=f6e1611840d' target=_blank style='color:#2F92EE;'>#机器#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61184, encryptionId=f6e1611840d, topicName=机器)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13dc16973127, createdName=ms6279672939590805, createdTime=Wed Mar 23 00:02:00 CST 2016, time=2016-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=72585, encodeId=24e3e258580, content=没有这个条件阿, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a6a1604604, createdName=Gsurgeon, createdTime=Tue Mar 22 11:47:00 CST 2016, time=2016-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=72563, encodeId=4197e256309, content=想参加, beContent=null, objectType=article, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=115b1703046, createdName=1de8665bm23(暂无匿称), createdTime=Tue Mar 22 09:08:00 CST 2016, time=2016-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=72437, encodeId=1214e243721, content=厉害厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Mon Mar 21 21:50:00 CST 2016, time=2016-03-21, status=1, ipAttribution=)]
    2016-03-22 1de8665bm23(暂无匿称)

    想参加

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1309471, encodeId=8c8513094e120, content=<a href='/topic/show?id=64ee5052ea7' target=_blank style='color:#2F92EE;'>#微创手术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50527, encryptionId=64ee5052ea7, topicName=微创手术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2b9b368, createdName=qingrejiedu, createdTime=Wed Mar 23 00:02:00 CST 2016, time=2016-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1316966, encodeId=b8b11316966e5, content=<a href='/topic/show?id=df8950505a2' target=_blank style='color:#2F92EE;'>#微创#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50505, encryptionId=df8950505a2, topicName=微创)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=644e456, createdName=vera_1203, createdTime=Wed Mar 23 00:02:00 CST 2016, time=2016-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1321877, encodeId=9d5713218e7e1, content=<a href='/topic/show?id=890c611854e' target=_blank style='color:#2F92EE;'>#机器人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61185, encryptionId=890c611854e, topicName=机器人)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d139492, createdName=xue8602, createdTime=Wed Mar 23 00:02:00 CST 2016, time=2016-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1582939, encodeId=2cc51582939f5, content=<a href='/topic/show?id=f6e1611840d' target=_blank style='color:#2F92EE;'>#机器#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61184, encryptionId=f6e1611840d, topicName=机器)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13dc16973127, createdName=ms6279672939590805, createdTime=Wed Mar 23 00:02:00 CST 2016, time=2016-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=72585, encodeId=24e3e258580, content=没有这个条件阿, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a6a1604604, createdName=Gsurgeon, createdTime=Tue Mar 22 11:47:00 CST 2016, time=2016-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=72563, encodeId=4197e256309, content=想参加, beContent=null, objectType=article, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=115b1703046, createdName=1de8665bm23(暂无匿称), createdTime=Tue Mar 22 09:08:00 CST 2016, time=2016-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=72437, encodeId=1214e243721, content=厉害厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Mon Mar 21 21:50:00 CST 2016, time=2016-03-21, status=1, ipAttribution=)]
    2016-03-21 milkshark

    厉害厉害

    0

相关资讯

源自昆虫的灵感

昆虫,无论它们是爬行还是飞翔,都生活在一个艰苦困顿的世界里。谁不曾踩到过一只蟑螂,然而抬起脚却看到这种动物一跃而起并迅速跑到门缝下逃之夭夭。如今,研究人员正在学习这些生物是如何做到弯曲而不被折断的。这项研究的结果远非解释为什么蟑螂很难被杀死那么简单。通过模拟赋予昆虫外骨骼和翅膀恢复力的刚性及柔性部分,生物机械学家正在制造更加强健的机器人。这种新型机器人可抗压、降低身形、钻入缝隙,今后或许可以用于救

机器人发展史(公元前1400-公元2015年),2045年有望超越人类

其实当今社会,我们人类已经在很多方面都离不开机器人的帮助。奇点大学校长库兹韦尔(Ray Kurzweil)认为,2045年是奇点时代的元年,在那年机器的智慧首次超过人类,机器将全面取代人类事务。摆在人类面前的只有两条道路:与机器融合,或者被机器毁灭。对于人类这一前景,目前业界说法不一。在日本,机器人已正在走进千家万户。就移动医疗而言,日本没有大量的所谓的轻问诊公司,但是却有大量的医疗机器人问世

世界首例在人类机体中进行的“柔性”机器人外科手术

图片来源:www.uic.edu 近日,来自伦敦大学国王学院的机器人专家、工程师及外科医生组成的研究团队首次利用“柔性”的手术机器人作为微创手术的一部分来在人类机体中进行操作实验,目的就是改善未来的外科手术实践,在专业外科医生的引导下,研究小组利用这种机器人对人类的尸体组织及医学模型成功进行了实践。 一旦名为套管针端口的结构通过腹部的小切口进入到机体中,这种新型机器人就会为外科医生提供来自

2016年5大机器人趋势,可能助力医疗发展

《麻省理工科技评论》(MIT Technology Review)网站今日评出了2016年全球最值得关注的5大机器人趋势,其中中国的机器人革命排名首位。 文章指出,中国正在进行一场大胆的的机器人革命,其在经济和技术方面的影响势必将席卷全球。此外,2016年很可能是无人机腾飞的一年,你今年的圣诞礼物很可能“从天而降”。 1. 中国的机器人革命 世界最大的经济体中国正在进行一

FDA:机器人已经可以给人做手术了

Flex®机器人系统。设计基于卡耐基梅隆大学的Howie Choset。这款通过口腔的进入人体的机器人能够让外科医生看到并且能够到达非常难到达的解剖区域。来自卡耐基梅隆大学的公司Medrobotics Corp.于2015年7月下旬发表声明,称其公司生产的Flex®机器人系统已经得到美国食品及药物管理局(FDA)的放行,可以在市场上销售了。这款机器人的设计基于该大学的机器人研究所的Howie Ch

时占祥:机器人在医疗应用上的现状和发展前景

12月12日,在中欧国际工商学院主办的2015中国健康产业创新平台奇璞峰会上,全球医生组织北京代表处负责人时占祥就《机器人在医疗应用上的现状和发展前景》发表了演讲,认为多个观点具启发性,特根据演讲实录整理如下,难免谬误,仅供学习参考。 机器人是在解决人类社会生产力问题 最近两年关于机器人的讨论非常热烈,其中一个比较激烈的观点是人工智能或者机器人是人类在自掘坟墓,这方面,霍金多次强调了类似的

Baidu
map
Baidu
map
Baidu
map